XBiotech Inc (4XB.MU)
Munich - Munich Delayed Price. Currency in EUR
Add to watchlist
At close: 08:05AM CEST
| Previous Close | 7.50 |
| Open | 7.50 |
| Bid | 7.80 x N/A |
| Ask | 8.00 x N/A |
| Day's Range | 7.50 - 7.50 |
| 52 Week Range | 3.06 - 9.10 |
| Volume | |
| Avg. Volume | 157 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | May 08, 2024 - May 13, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Simply Wall St.XBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 44% stake, while 44% is held by insiders
Key Insights XBiotech's significant retail investors ownership suggests that the key decisions are influenced by...
GlobeNewswireXBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
XBiotech Architectural Rendition of XBiotech’s Planned R&D Facility XBiotech Architectural Rendition of XBiotech’s Planned R&D Facility AUSTIN, Texas, Jan. 04, 2024 (GLOBE NEWSWIRE) -- XBiotech Inc. today announced that it plans to expand it’s campus headquarters with the construction of a new, state-of-the-art research and development facility. XBiotech has received City of Austin approval to begin excavation for site preparation and groundwork is expected to begin 1st quarter 2024. The new fou
- Simply Wall St.
Companies Like XBiotech (NASDAQ:XBIT) Are In A Position To Invest In Growth
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
© 2024 Yahoo. All rights reserved.